Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01129583 · ClinicalTrials.gov registry record · NA
Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01129583 is a NA study that has completed, run by Columbia University. The registered enrollment target is 18 participants.
The verdict
NCT01129583, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a randomized double blind placebo controlled study to investigate the hypothesis that injection of botulinum toxin A into the muscles surrounding the elbow following the surgical treatment of an elbow fracture will reduce postoperative stiffness and improve function.
Interventions
- DRUG Saline
- DRUG Botulinum Toxin Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2003-11 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01129583
The ClinicalTrials.gov registry entry for NCT01129583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT01129583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01129583 about?
NCT01129583 is a clinical study titled "Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness". This is a randomized double blind placebo controlled study to investigate the hypothesis that injection of botulinum toxin A into the muscles surrounding the elbow following the surgical treatment of an elbow fracture will reduce postoperative stiffness and improve function.
What is the current status of trial NCT01129583?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2003-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01129583?
The interventions under investigation include: Saline (DRUG), Botulinum Toxin Type A (DRUG).
Who is sponsoring clinical trial NCT01129583?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.